Member Posts > Cardiol Therapeutics: Leading Cannabidiol Research for Cardiovascular Innovation
Cardiol Therapeutics (NASDAQ: CRDL; TSX: CRDL) is pioneering cannabidiol-based therapies for cardiovascular diseases. Through scientific events and investor conferences, the company showcases the potential of CardiolRx™ as a novel anti-inflammatory therapy.
Upcoming Research & Innovation Events
📅 TD Cowen 45th Annual Health Care Conference (March 3-5, 2025)
• Panel on the therapeutic potential of cannabidiol in heart disease.
📅 37th Annual ROTH Conference (March 16-18, 2025)
• Key discussions on emerging biotech innovations.
Recent Scientific Highlights
🔬 AHA Scientific Sessions 2024 (Nov 18, 2024)
• Presentation of CardiolRx™'s impact on reducing fibrosis and inflammation.
📢 Stay updated on cutting-edge cannabidiol research:

#Biotech #Investing #StockMarket #CardiolTherapeutics #NASDAQ #Healthcare #Pharma #Finance #MarketNews #HeartHealth #MedicalInnovation #Myocarditis #Pericarditis #HealthcareResearch #CannabidiolResearch #CardiolRx #LifeSciences #BiotechConference #InvestorUpdates